Immunotherapy, a rapidly evolving field in oncology, is revolutionizing the way we treat cancer. By harnessing the power of the body's immune system, it offers a less toxic and potentially more effective alternative to traditional therapies. As physicians, understanding the intricacies of immunotherapy is crucial for effective patient management.
Immunotherapy works by stimulating or restoring the immune system's ability to fight cancer. It can be broadly classified into two categories: active immunotherapies, which stimulate the immune system to attack cancer cells, and passive immunotherapies, which use immune system components created in the lab to enhance the body's cancer-fighting abilities.
There are several types of immunotherapies, including immune checkpoint inhibitors, cancer vaccines, and CAR-T cell therapy. Immune checkpoint inhibitors work by blocking proteins that prevent immune cells from attacking cancer. Cancer vaccines, on the other hand, are designed to provoke an immune response against specific cancer antigens. CAR-T cell therapy involves genetically modifying T cells to enhance their ability to find and kill cancer cells.
While immunotherapy has shown promising results, it's not without side effects. These can range from mild flu-like symptoms to severe autoimmune reactions. As physicians, being able to recognize and manage these side effects is paramount to ensuring patient safety and treatment efficacy.
Immunotherapy is a powerful tool in the fight against cancer, offering hope to many patients who have exhausted other treatment options. However, its complexity necessitates a thorough understanding of its mechanisms, types, and potential side effects. As physicians, continuous learning and adaptation are crucial to maximizing the benefits of this groundbreaking approach and delivering the best possible care to our patients.
1.
FDA Declines to Approve Achieve Life Sciences' Smoking-cessation Drug
2.
Uncovered biology underlies a novel drug used to treat triple-negative breast cancer.
3.
Chemotherapy damage to non-cancer cells may be the cause of breast cancer recurrence.
4.
Never in a million years did I think I'd have to limit my chemotherapy.
5.
Treating Depression: Crucial for Recovery From Fibromyalgia
1.
HCC in Melanoma: Role of HCC Codes and Moderate Whole Body Hyperthermia
2.
Clinical Analysis of Prostate Cancer
3.
Sorafenib: Understanding the science behind a powerful cancer drug
4.
Early-Onset GI Cancers: Screening, AI Innovations & Research Advances 2025
5.
Comprehensive Breakthroughs in Oncology for Better Care
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Understanding the Evolution in Lung Cancer- An Initiative from Manipal Hospitals: Further Discussion
2.
Experts' Opinion on the Goal of Treatment of Patients with Relapsed Adult B-cell ALL
3.
A Continuation to Deep Dive Into EGFR Mutation Positive Non-Small Cell Lung Cancer
4.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion
5.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation